Document Detail


Genetic and clinical correlates of early-outgrowth colony-forming units.
MedLine Citation:
PMID:  21493818     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Several bone marrow-derived cell populations may have angiogenic activity, including cells termed endothelial progenitor cells. Decreased numbers of circulating angiogenic cell populations have been associated with increased cardiovascular risk. However, few data exist from large, unselected samples, and the genetic determinants of these traits are unclear.
METHODS AND RESULTS: We examined the clinical and genetic correlates of early-outgrowth colony-forming units (CFUs) in 1799 participants of the Framingham Heart Study (mean age, 66 years; 54% women). Among individuals without cardiovascular disease (n = 1612), CFU number was inversely related to advanced age (P = 0.004), female sex (P = 0.04), and triglycerides (P = 0.008) and positively related to hormone replacement (P = 0.008) and statin therapy (P = 0.027) in stepwise multivariable analyses. Overall, CFU number was inversely related to the Framingham risk score (P = 0.01) but not with prevalent cardiovascular disease. In genome-wide association analyses in the entire sample, polymorphisms were associated with CFUs at the MOSC1 locus (P = 3.3 × 10(-7)) and at the SLC22A3-LPAL2-LPA locus (P = 4.9 × 10(-7)), a previously replicated susceptibility locus for myocardial infarction. Furthermore, alleles at the SLC22A3-LPAL2-LPA locus that were associated with decreased CFUs were also related to increased risk of myocardial infarction (P = 1.1 × 10(-4)).
CONCLUSIONS: In a community-based sample, early-outgrowth CFUs are inversely associated with select cardiovascular risk factors. Furthermore, genetic variants at the SLC22A3-LPAL2-LPA locus are associated with both decreased CFUs and an increased risk of myocardial infarction. These findings are consistent with the hypothesis that decreased circulating angiogenic cell populations promote susceptibility to myocardial infarction.
Authors:
Stanley Y Shaw; Susan Cheng; L Adrienne Cupples; Martin G Larson; Elizabeth L McCabe; Julius S Ngwa; Ying A Wang; Roderick P Martin; Rachael J Klein; Basma Hashmi; Olujimi A Ajijola; Evan Lau; Christopher J O'Donnell; Ramachandran S Vasan; Kenneth S Cohen; Thomas J Wang
Related Documents :
22416808 - The use of pneumoperitoneum during laparoscopic surgery as a model to study pathophysio...
21823078 - Diffuse coronary ectasia complicated by myocardial infarction in a patient with multipl...
21931988 - Tissue doppler imaging is useful for predicting the need for inotropic support after ca...
21697608 - Transmural perfusion gradient in adenosine triphosphate stress myocardial perfusion com...
14678128 - Randomized controlled trial of fixed rate versus rate responsive pacing after radiofreq...
9148328 - Cattell's 16 pf and psy inventory: relationship between personality traits and behavior...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-04-14
Journal Detail:
Title:  Circulation. Cardiovascular genetics     Volume:  4     ISSN:  1942-3268     ISO Abbreviation:  Circ Cardiovasc Genet     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-15     Completed Date:  2011-09-30     Revised Date:  2013-03-04    
Medline Journal Info:
Nlm Unique ID:  101489144     Medline TA:  Circ Cardiovasc Genet     Country:  United States    
Other Details:
Languages:  eng     Pagination:  296-304     Citation Subset:  IM    
Affiliation:
Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Bone Marrow Cells* / cytology,  physiology
Cardiovascular Diseases / physiopathology*
Endothelial Cells* / cytology,  physiology
Female
Humans
Male
Middle Aged
Polymorphism, Single Nucleotide
Risk Factors
Stem Cells* / cytology,  physiology
Grant Support
ID/Acronym/Agency:
N01 HC025195/HC/NHLBI NIH HHS; N01-HC-25195/HC/NHLBI NIH HHS; R01 HL083197-04/HL/NHLBI NIH HHS; R01 HL093328/HL/NHLBI NIH HHS; R01 HL093328-04/HL/NHLBI NIH HHS; R01-HL083197/HL/NHLBI NIH HHS; R01-HL93328/HL/NHLBI NIH HHS
Comments/Corrections
Comment In:
Circ Cardiovasc Genet. 2011 Jun;4(3):218-20   [PMID:  21673309 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  KIF6 Polymorphism and the Efficacy of Rosuvastatin in Primary Prevention.
Next Document:  Coronary artery endothelial transcriptome in vivo: identification of endoplasmic reticulum stress an...